A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
Stopped The study was terminated early based on the results of a planned interim analysis.
Conditions
Interventions
- DRUG: Placebo Cream
- DRUG: Ruxolitinib Phosphate Cream
Sponsor
Incyte Corporation